Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

The FDA slapped a ... for moderate to severe hot flashes caused by menopause, highlighting the known risk of rare but serious liver injury associated with use of the drug, the agency announced.

Deciding whether to start hormone therapy during the menopause transition, the life phase that's the bookend to puberty and ...

Canadian health experts warn the fallout from thousands of job cuts at the U.S. Food and Drug Administration on April 1 could ...

Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of at least $1 billion, as it seeks to strengthen its pharmaceuticals business ...

“If you keep using the same lice medication, they will eventually ... Dracker began prescribing spinosad (brand name Natroba), an FDA-approved topical lice removal treatment.

Because of this definition, they have not been subject to reports of efficacy and adverse events compared with US FDA-approved hormones ... Evidence for Relief of Hot Flashes & Vaginal Dryness ...

Originally approved to treat Type 2 diabetes, this injectable medication has become popular ... specialist after struggling with severe hot flashes during perimenopause. “I was on this TV ...

Forgetfulness and loss of focus are among the most frustrating aspects of midlife hormonal shifts. MenoRescue's inclusion of ...